EVH Earnings Drop 31%
Evolent Health (NYSE:EVH), a company specializing in technology-enabled specialty care management solutions for healthcare providers and payers, reported its Q2 2025 earnings on August 7, 2025. The headline from the company's results was a miss on both GAAP revenue and adjusted earnings per share (non-GAAP) compared to market expectations, alongside a continued decline in its core per-member metrics. GAAP revenue totaled $444.3 million versus an analyst estimate of $459.6 million, and non-GAAP diluted loss per share was $(0.10), falling short of the $0.07 anticipated profit. Adjusted EBITDA margin expanded modestly to 8.5% from 8.0% a year ago, but absolute adjusted EBITDA dropped to $37.5 million from $52.0 million year over year. Overall, the quarter showed ongoing profitability challenges for the company, mixed with some margin stabilization and progress in specialty care and automation initiatives.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
Evolent Health delivers specialty care management services and proprietary technology platforms to healthcare providers, health plans, and risk-bearing organizations across the U.S. Its focus areas include complex, high-cost conditions such as oncology, cardiology, and musculoskeletal care. The company’s value proposition centers on managing rising healthcare costs and improving patient outcomes by integrating evidence-based care pathways and AI-enabled clinical workflows via platforms like Identifi and CarePro.
Source Fool.com
